Who's Driving? Switch of Drivers in Immunotherapy-Treated Progressing Sinonasal Melanoma.

disease monitoring immunotherapy mucosal melanoma oncogenic driver sinonasal cancer tumor heterogeneity

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
31 May 2021
Historique:
received: 30 03 2021
revised: 12 05 2021
accepted: 28 05 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 3 6 2021
Statut: epublish

Résumé

Mucosal melanoma can be driven by various driver mutations in genes such as

Identifiants

pubmed: 34072863
pii: cancers13112725
doi: 10.3390/cancers13112725
pmc: PMC8198298
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Cancer League Zurich
ID : Investigation of novel marker combinations to predict response to immunotherapy in mucosal melanoma

Références

Cancers (Basel). 2019 Sep 07;11(9):
pubmed: 31500314
Acta Derm Venereol. 2020 Jan 23;100(1):adv00040
pubmed: 31774543
N Engl J Med. 2015 May 21;372(21):2018-28
pubmed: 25891174
Cancer Immunol Immunother. 2019 Jul;68(7):1171-1178
pubmed: 31172258
Nat Commun. 2020 Aug 27;11(1):4306
pubmed: 32855398
Cancer Discov. 2016 Feb;6(2):202-16
pubmed: 26645196
Eur J Cancer. 2018 Jul;98:10-16
pubmed: 29843107
J Clin Oncol. 2013 Sep 10;31(26):3182-90
pubmed: 23775962
N Engl J Med. 2012 Jun 28;366(26):2443-54
pubmed: 22658127
Nat Commun. 2014 Dec 02;5:5694
pubmed: 25452114
Oncotarget. 2016 Nov 22;7(47):77163-77174
pubmed: 27791198
Ann Oncol. 2016 Sep;27(suppl 5):v136-v137
pubmed: 27664250
J Clin Oncol. 2017 Jan 10;35(2):226-235
pubmed: 28056206
Int J Oncol. 2018 Apr;52(4):1071-1080
pubmed: 29532857
Nat Genet. 2016 Dec;48(12):1500-1507
pubmed: 27749841
Lab Invest. 2017 Sep;97(9):1063-1071
pubmed: 28737763
Cancer Discov. 2014 Jan;4(1):61-8
pubmed: 24265154
Nat Med. 2015 Jul;21(7):751-9
pubmed: 26099045
N Engl J Med. 2015 Jul 2;373(1):23-34
pubmed: 26027431
Crit Rev Oncol Hematol. 2017 Apr;112:136-152
pubmed: 28325255
Melanoma Res. 2015 Dec;25(6):503-9
pubmed: 26352784
Lancet Oncol. 2013 Mar;14(3):249-56
pubmed: 23414587
Clin Cancer Res. 2016 Mar 15;22(6):1499-509
pubmed: 26515496
Clin Cancer Res. 2021 Apr 15;27(8):2226-2235
pubmed: 33509808
Cancer Immunol Res. 2015 Mar;3(3):288-295
pubmed: 25736262
Nature. 2017 May 11;545(7653):175-180
pubmed: 28467829
N Engl J Med. 2016 Sep 1;375(9):819-29
pubmed: 27433843

Auteurs

Sandra N Freiberger (SN)

Department of Pathology and Molecular Pathology, University Hospital Zurich, 8091 Zurich, Switzerland.
Faculty of Medicine, University of Zurich, 8006 Zurich, Switzerland.

Patrick Turko (P)

Department of Dermatology, University Hospital Zurich, 8058 Zurich, Switzerland.

Martin Hüllner (M)

Faculty of Medicine, University of Zurich, 8006 Zurich, Switzerland.
Department of Nuclear Medicine, University Hospital Zurich, 8091 Zurich, Switzerland.

Reinhard Dummer (R)

Faculty of Medicine, University of Zurich, 8006 Zurich, Switzerland.
Department of Dermatology, University Hospital Zurich, 8058 Zurich, Switzerland.

Grégoire B Morand (GB)

Faculty of Medicine, University of Zurich, 8006 Zurich, Switzerland.
Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, 8091 Zurich, Switzerland.
Department of Otolaryngology, Head and Neck Surgery, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada.

Mitchell P Levesque (MP)

Faculty of Medicine, University of Zurich, 8006 Zurich, Switzerland.
Department of Dermatology, University Hospital Zurich, 8058 Zurich, Switzerland.

David Holzmann (D)

Faculty of Medicine, University of Zurich, 8006 Zurich, Switzerland.
Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, 8091 Zurich, Switzerland.

Niels J Rupp (NJ)

Department of Pathology and Molecular Pathology, University Hospital Zurich, 8091 Zurich, Switzerland.
Faculty of Medicine, University of Zurich, 8006 Zurich, Switzerland.

Classifications MeSH